NEW DELHI: Shares of Sanofi India traded 3.6 per cent up in Wednesday's trade at 09:21 am.
Around 4,660 shares changed hands on the counter.
The stock opened at Rs 7650.0 and touched an intraday high and low of Rs 7650.0 and Rs 7439.95, respectively, in the session so far.
Pharma majors Sanofi and GSK said they have joined hands to develop a vaccine for Covid-19.
The companies in a joint statement said they have signed a letter of intent to develop an adjuvanted vaccine for Covid-19.The stock quoted a 52-week high of Rs 7539.5 and a 52-week low of Rs 5280.Financials Sanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 16619.13 crore) operating in the Pharmaceuticals sector.
The company reported net profit after tax of Rs 97.30 crore for the quarter ended 31 December, 2019.
For the same quarter, the company has reported Standalone sales of Rs 826.30 crore, up 6.06 per cent from last quarter Sales of Rs 779.10 crore and up 22.11 per cent from last year same quarter Sales of Rs 676.70 crore.Sanofi India key products/revenue segments include pharmaceutical products which contributed Rs 2594.00 crore to sales value (93.70 per cent of total sales), sale of services which contributed Rs 145.70 crore to sales value (5.26 per cent of total sales), export incentives which contributed Rs 26.60 crore to sales value (0.96 per cent of total sales), scrap which contributed Rs 1.40 crore to sales value (0.05 per cent of total sales) and other operating revenue which contributed Rs .60 crore to sales value (0.02 per cent of total sales)for the year ending 31-dec-2018.
Promoter holding Promoters held 60.396057 per cent stake in the company as of quarter ended 31st Dec 2019.Valuation ratio It quoted a price-to-earnings ratio of 40.1 and price to book value of 6.79.